GMP Cell Banking Service Market 2030 By Cell Type (Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization) and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Information Technology | Pages : 187 Pages | Published On : Apr 2024

         
     

The GMP Cell Banking Service Market was valued USD 874.01 Million in 2023 and projected to reach USD 2,147.04 Million by 2030, growing at a CAGR of 13.7% during the forecast period of 2023-2030.

GMP Cell Banking Service Market Size


Graph
             2019                         2023-2030      

ReportDetails
Market Size ValueUSD 874.01 Million in 2023
Market Size ValueUSD 2,147.04 Million by 2030
CAGRCAGR of 13.7%
Forecast Period2023-2030
Historic Data2019
Segments CoveredCell Type, End User and Region
Geographics CoveredNorth America, Europe, Asia Pacific, and RoW

Major vendors in the global GMP Cell Banking Service Market WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Merck KGaA, Lonza, SGS Life Sciences Ltd., ViruSure, Austrianova, Goodwin Biotechnology, Paragon Bioservices, Bio Reliance, Sartorius, Thermo Fisher, BSL Bioservice, Cleancells, Covance and Others

Market Overview

The GMP (Good Manufacturing Practice) Cell Banking Service Market encompasses a vital segment within the biopharmaceutical industry, providing essential services for the storage and maintenance of master cell banks (MCBs) and working cell banks (WCBs) compliant with rigorous regulatory standards. This market is characterized by the increasing demand for advanced biologics and cell-based therapies, driving the need for reliable cell banking solutions to ensure product quality, safety, and consistency. Key players in the market offer a range of services including cell line characterization, cell line storage, and distribution, catering to the diverse needs of biopharmaceutical companies, contract research organizations (CROs), and academic institutions engaged in drug development and bioprocessing. Factors such as stringent regulatory requirements, technological advancements in cell culture techniques, and growing investments in biopharmaceutical R&D contribute to the steady growth and evolution of the GMP Cell Banking Service Market.

Growing Biopharmaceutical Sector

The growing biopharmaceutical sector serves as a significant driver for the expansion of the GMP Cell Banking Service Market due to its reliance on advanced biologics and cell-based therapies. With an increasing focus on personalized medicine and novel treatment modalities, biopharmaceutical companies are continually developing innovative therapeutics that require precise cell line development and banking services to ensure product quality, safety, and efficacy. Moreover, the rising prevalence of chronic diseases, coupled with the aging population, further amplifies the demand for biopharmaceuticals, thereby fueling the need for reliable GMP-compliant cell banking solutions. As biopharmaceutical companies strive to accelerate drug development pipelines and bring new therapies to market, the importance of robust cell banking services becomes paramount, driving sustained growth in the market.

Market Dynamics

Drivers:

  • Rising Complexity of Cell-Based Therapies
  • Growing Demand for Gene and Cell Therapies
  • The growing trend towards personalized medicine

Opportunities:

  • Advancement in Drug Delivery Technologies
  • Surge in demand for Personalized Medicine and Gene Therapy

The Rising Demand For GMP Compliant Services

The rising demand for GMP (Good Manufacturing Practice) compliant services is a notable trend propelling the growth of the GMP Cell Banking Service Market. This trend is primarily driven by stringent regulatory requirements governing the biopharmaceutical industry, necessitating adherence to rigorous quality standards throughout the drug development and manufacturing process. As biopharmaceutical companies increasingly prioritize regulatory compliance to ensure product safety and efficacy, the demand for GMP-compliant cell banking services surges. These services play a crucial role in supporting biopharmaceutical firms in achieving regulatory approval by providing comprehensive solutions for the storage, characterization, and distribution of master cell banks (MCBs) and working cell banks (WCBs) in compliance with GMP guidelines. Consequently, the market witnesses sustained growth as companies seek reliable partners offering expertise in GMP-compliant cell banking services to navigate the complex regulatory landscape effectively.

North America dominates the market for GMP Cell Banking Service Market.

North America has emerged as a dominant force in the GMP (Good Manufacturing Practice) Cell Banking Service Market primarily due to several factors. Firstly, the region boasts advanced healthcare infrastructure, including state-of-the-art research facilities and regulatory frameworks that prioritize safety and quality standards, thereby fostering a conducive environment for cell banking services. Secondly, a robust biotechnology and pharmaceutical industry presence in North America has propelled the demand for GMP-compliant cell banking services to support drug development, clinical trials, and bio manufacturing processes. Additionally, North America benefits from a strong ecosystem of academic institutions, biotech startups, and established companies, facilitating collaboration and innovation in cell therapy and regenerative medicine. Combined, these factors position North America at the forefront of the GMP Cell Banking Service Market, driving its dominance in the global landscape.

Mammalian Segments is anticipated to hold the Largest Market Share during the Forecast Period

Based on the Cell Type segment categorized into Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others. Hospitals has a major share in the GMP Cell Banking Service Market. The mammalian cell type segment holds the major share. This dominance can be attributed to several factors. Mammalian cells, including human cells, are widely utilized in biopharmaceutical production, particularly for the development of cell-based therapies, monoclonal antibodies, and recombinant proteins. These cells offer significant advantages such as the ability to produce complex proteins with post-translational modifications essential for therapeutic efficacy. Moreover, mammalian cell lines are extensively employed in preclinical and clinical studies, necessitating reliable and compliant cell banking services to ensure product safety, consistency, and regulatory compliance. Additionally, the increasing focus on personalized medicine and the development of advanced therapies further fuel the demand for mammalian cell banking services, reinforcing its position as the leading segment in the GMP Cell Banking Service Market.

Major Segmentations Are Distributed as follows:

  • By Cell Type
    • Mammalian
    • Microbial
    • Insect
    • Yeast
    • Avian
    • Stem Cell
    • Others
  • By End User
    • Biopharmaceutical Companies
    • Contract Manufacturing Organization
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Thailand
      • Indonesia
      • Malaysia
      • Vietnam
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Nigeria
      • Egypt
      • Israel
      • Turkey
      • Rest of Middle East & Africa

Recent Developments

  • April 2022: FUJIFILM Corporation acquired Atara Biotherapeutics, a US-based cell therapy manufacturing company. This move expands FUJIFILM's capabilities in GMP cell banking for both clinical and commercial cell therapies.
  •  June 2021: Mecart, a company specializing in creating biotech cleanrooms, built a Grade C cell banking cleanroom equipped for cell banking operations. This indicates their focus on entering the GMP cell banking service market.

GMP Cell Banking Service Market Report Gives Answers to Following Key Questions:

  • What will be the GMP Cell Banking Service Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of GMP Cell Banking Service Market?
  • What are the main forces behind the worldwide GMP Cell Banking Service Market? Which companies dominate the GMP Cell Banking Service Market?
  • Which companies dominate the GMP Cell Banking Service Market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global GMP Cell Banking Service industry's suppliers' opportunities and dangers in GMP Cell Banking Service Market?
  • What is the GMP Cell Banking Service industry's regional sales, income, and pricing analysis? In the GMP Cell Banking Service Market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the GMP Cell Banking Service Market?
  • What are the main geographical areas for various industries that are anticipated to observe an astounding expansion in GMP Cell Banking Service Market?
  • What are the dominant revenue-generating regions for GMP Cell Banking Service Market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main GMP Cell Banking Service Market trends that are influencing the market's expansion?
  • Which key product categories dominate the GMP Cell Banking Service Market? What are the GMP Cell Banking Service Market’s main applications?
  • In the coming years, which GMP Cell Banking Service Market technology will dominate the market?

Reason to purchase this GMP Cell Banking Service Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global GMP Cell Banking Service Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different GMP Cell Banking Service Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global GMP Cell Banking Service Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global GMP Cell Banking Service Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top GMP Cell Banking Service Market providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.

TOC

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com